Predicting the probability of pT3 or higher pathological stage at radical prostatectomy: COVID19-specific considerations

Predicting the probability of pT3 or higher pathological stage at radical prostatectomy: COVID19-specific considerations

BackgroundWe tested whether a model identifying prostate cancer (PCa) patients at risk of pT3-4/pN1 can be developed for use during COVID19 pandemic, in order to guarantee appropriate treatment to patients harboring advanced disease patients without compromising sustainability of care delivery.Metho...

Full description

Bibliographic Details
Main Authors: Luigi Nocera, Lara F. Stolzenbach, Claudia Collà Ruvolo, Mike Wenzel, Christoph Wurnschimmel, Zhe Tian, Giorgio Gandaglia, Nicola Fossati, Vincenzo Mirone, Felix K. H. Chun, Shahrokh F. Shariat, Markus Graefen, Fred Saad, Francesco Montorsi, Alberto Briganti, Pierre I. Karakiewicz
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Oncology
Subjects:
radical prostatectomy
Pt3+
PT3
pT4
PCA
prostate cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.990851/full

Similar Items

Similar Items